Lista de obras - Daniel R van Langenberg - Dominio Público Uruguay

A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease

artículo científico publicado en 2011

A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease

scientific article published on 07 May 2020

Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change

artículo científico publicado en 2010

Are All Symptoms in Patients in IBD Due to Occult Inflammation?

Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care

artículo científico publicado en 2013

Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti-TNF prescribing

artículo científico publicado en 2015

Characterization of ulcerative colitis-associated constipation syndrome (proximal constipation)

scientific article published on 05 August 2018

Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort

artículo científico publicado en 2013

Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'.

artículo científico publicado en 2011

Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.

artículo científico publicado en 2013

Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome

artículo científico publicado en 2013

Editorial: direct costs are only the tip of the iceberg in inflammatory bowel disease

scientific article published on 01 September 2020

Editorial: methotrexate vs azathioprine-do differential rates of discontinuation settle the debate? Authors' reply

scientific article published on 01 November 2020

Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.

artículo científico publicado en 2017

Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study

artículo científico publicado en 2014

Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study

artículo científico publicado en 2019

Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status

artículo científico publicado en 2011

Gastrointestinal: acute haemorrhage from a Dieulafoy lesion within a gastric diverticulum managed endoscopically

artículo científico publicado en 2009

Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease

artículo científico publicado en 2013

Inflammatory bowel disease serology in Asia and the West.

artículo científico publicado en 2013

Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail

scientific article published on 01 August 2020

Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it!

scientific article published on 01 November 2018

Letter: rationalising aminosalicylates in inflammatory bowel disease

scientific article published on 01 November 2020

Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval?

scientific article published on 01 August 2020

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease

artículo científico publicado en 2018

Maintaining Muscle Strength in Crohn’s Disease: Can a Vitamin D Daily Keep Muscle Loss Away? ⬇️

artículo científico publicado el 30 de enero de 2013

Poor predictive value of breath hydrogen response for probiotic effects in IBS.

artículo científico publicado en 2015

Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit

artículo científico publicado en 2010

Predicting Response after Infliximab Salvage in Acute Severe Ulcerative Colitis.

artículo científico publicado en 2017

Satisfaction with patient-doctor relationships in inflammatory bowel diseases: Examining patient-initiated change of specialist ⬇️

artículo científico publicado el 14 de mayo de 2012

Sleep and physical activity measured by accelerometry in Crohn's disease

artículo científico publicado en 2015

Systematic review: fatigue in inflammatory bowel disease.

artículo científico publicado en 2010

The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience

artículo científico publicado en 2010

The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea

artículo científico publicado en 2010

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

artículo científico publicado en 2020

Un-promoted issues in inflammatory bowel disease: opportunities to optimize care.

artículo científico publicado en 2009

Lista de obras de Daniel R van Langenberg

A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease

A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's disease

Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change

Are All Symptoms in Patients in IBD Due to Occult Inflammation?

Assessing patient satisfaction in inflammatory bowel disease using the QUOTE-IBD survey: a small step for clinicians, a potentially large step for improving quality of care

Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti-TNF prescribing

Characterization of ulcerative colitis-associated constipation syndrome (proximal constipation)

Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort

Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'.

Delving into disability in Crohn's disease: dysregulation of molecular pathways may explain skeletal muscle loss in Crohn's disease.

Dietary sorbitol and mannitol: food content and distinct absorption patterns between healthy individuals and patients with irritable bowel syndrome

Editorial: direct costs are only the tip of the iceberg in inflammatory bowel disease

Editorial: methotrexate vs azathioprine-do differential rates of discontinuation settle the debate? Authors' reply

Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.

Factors associated with physical and cognitive fatigue in patients with Crohn's disease: a cross-sectional and longitudinal study

Faecal calprotectin delivers on convenience, cost reduction and clinical decision-making in inflammatory bowel disease: a real-world cohort study

Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status

Gastrointestinal: acute haemorrhage from a Dieulafoy lesion within a gastric diverticulum managed endoscopically

Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease

Inflammatory bowel disease serology in Asia and the West.

Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail

Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it!

Letter: rationalising aminosalicylates in inflammatory bowel disease

Letter: ustekinumab dose intensification for loss of response-should we re-induce before shortening the dose interval?

Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease

Maintaining Muscle Strength in Crohn’s Disease: Can a Vitamin D Daily Keep Muscle Loss Away? ⬇️

Poor predictive value of breath hydrogen response for probiotic effects in IBS.

Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit

Predicting Response after Infliximab Salvage in Acute Severe Ulcerative Colitis.

Satisfaction with patient-doctor relationships in inflammatory bowel diseases: Examining patient-initiated change of specialist ⬇️

Sleep and physical activity measured by accelerometry in Crohn's disease

Systematic review: fatigue in inflammatory bowel disease.

The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience

The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea

Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease

Un-promoted issues in inflammatory bowel disease: opportunities to optimize care.